(Q48614095)

13 February 2018

title

Increased body mass index (BMI) in male narcoleptic patients, but not in HLA-DR2-positive healthy male volunteers. (English)

1 reference

13 February 2018

0 references

Frank Geller

4

0 references

Johannes Hebebrand

7

object named as

Johannes Hebebrand

1 reference

13 February 2018

Andreas Schuld

1

1 reference

13 February 2018

Pierre A Beitinger

2

1 reference

13 February 2018

Mira Dalal

3

1 reference

13 February 2018

Thomas C Wetter

5

1 reference

13 February 2018

Ekkehard D Albert

6

1 reference

13 February 2018

Thomas Pollmächer

8

1 reference

13 February 2018

publication date

1 July 2002

1 reference

13 February 2018

number of pages

5

1 reference

inferred from page(s)

published in

Sleep Medicine

1 reference

13 February 2018

volume

3

1 reference

13 February 2018

issue

4

1 reference

13 February 2018

page(s)

335-339

1 reference

13 February 2018

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

1 reference

7 January 2021

REM sleep disinhibition at sleep onset: a comparison between narcolepsy and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Genetic and familial aspects of narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Hypocretin (orexin) deficiency in human narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Normal plasma levels of orexin A (hypocretin-1) in narcoleptic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Reduced number of hypocretin neurons in human narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Aprepro-orexingene polymorphism is associated with narcolepsy: Table 1

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Orexins and orexin receptors: implication in feeding behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Narcolepsy: a key role for hypocretins (orexins)

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Increased body-mass index in patients with narcolepsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Increased prevalence of obesity in narcoleptic patients and relatives.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Reduced leptin levels in human narcolepsy

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Use of percentiles for the body mass index in anorexia nervosa: diagnostic, epidemiological, and therapeutic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Genetics of body-weight regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Circadian temperature and activity rhythms in unmedicated narcoleptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Current and potential drugs for treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Down regulation of the prepro-orexin gene expression in genetically obese mice

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

The disease burden associated with overweight and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Obesity as a medical problem

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Obstructive sleep apnea

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Narcolepsy and obesity: remission of severe cataplexy with sibutramine.

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

The effects of leptin on REM sleep and slow wave delta in rats are reversed by food deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS1389-9457%2802%2900012-6

7 January 2021

10.1016/S1389-9457(02)00012-6

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018